Acutus Medical, Inc. (AFIB)
- Previous Close
0.1631 - Open
0.1631 - Bid 0.1698 x 100
- Ask --
- Day's Range
0.1631 - 0.1883 - 52 Week Range
0.1600 - 1.0900 - Volume
724,623 - Avg. Volume
2,351,885 - Market Cap (intraday)
5.185M - Beta (5Y Monthly) 0.20
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4100 - Earnings Date May 9, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.50
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.
www.acutusmedical.comRecent News: AFIB
Performance Overview: AFIB
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AFIB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AFIB
Valuation Measures
Market Cap
5.19M
Enterprise Value
21.26M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.71
Price/Book (mrq)
--
Enterprise Value/Revenue
2.97
Enterprise Value/EBITDA
-3.99
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-13.80%
Return on Equity (ttm)
-32.16%
Revenue (ttm)
7.16M
Net Income Avi to Common (ttm)
-11.92M
Diluted EPS (ttm)
-0.4100
Balance Sheet and Cash Flow
Total Cash (mrq)
22.4M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
8.17M
Research Analysis: AFIB
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell